European Biotech Acquisition Corp
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.5
- Today's High:
- $0.5499
- Open Price:
- $0.5499
- 52W Low:
- $0.02
- 52W High:
- $0.7355
- Prev. Close:
- $0.55
- Volume:
- 18331
Company Statistics
- Market Cap.:
- $0
- Book Value:
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
European Biotech Acquisition Corp had its IPO on 2021-05-13 under the ticker symbol EBACW.
The company operates in the sector and industry. European Biotech Acquisition Corp has a staff strength of 0 employees.
Stock update
Shares of European Biotech Acquisition Corp opened at $0.55 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.5 - $0.55, and closed at $0.52.
This is a -6.36% slip from the previous day's closing price.
A total volume of 18,331 shares were traded at the close of the day’s session.
In the last one week, shares of European Biotech Acquisition Corp have increased by +11.38%.
European Biotech Acquisition Corp's Key Ratios
European Biotech Acquisition Corp has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months European Biotech Acquisition Corp’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures European Biotech Acquisition Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, European Biotech Acquisition Corp’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q4, European Biotech Acquisition Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
European Biotech Acquisition Corp’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into European Biotech Acquisition Corp’s profitability.
European Biotech Acquisition Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
European Biotech Acquisition Corp stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $129.75 million
- Total Liabilities
- $795568.00
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
European Biotech Acquisition Corp ended 2024 with $129.75 million in total assets and $0 in total liabilities. Its intangible assets were valued at $129.75 million while shareholder equity stood at $-8058896.00.
European Biotech Acquisition Corp ended 2024 with $0 in deferred long-term liabilities, $795568.00 in other current liabilities, in common stock, $-8059261.00 in retained earnings and $0 in goodwill. Its cash balance stood at $308488.00 and cash and short-term investments were $308488.00. The company’s total short-term debt was $0 while long-term debt stood at $0.
European Biotech Acquisition Corp’s total current assets stands at $356637.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $359537.00 and inventory worth $0.
In 2024, European Biotech Acquisition Corp's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, European Biotech Acquisition Corp paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.52
- 52-Week High
- $0.7355
- 52-Week Low
- $0.02
- Analyst Target Price
- $
European Biotech Acquisition Corp stock is currently trading at $0.52 per share. It touched a 52-week high of $0.7355 and a 52-week low of $0.7355. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.31 and 200-day moving average was $0.28 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About European Biotech Acquisition Corp
Most Active
Top Gainers
Top Losers
About
European Biotech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2021 and is based in Amsterdam, the Netherlands.